Ronan Kelly
0000-0002-6446-2103
Baylor Scott & White Charles A Sammons Cancer Center Dallas
1 paper found
Refreshing results…
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Missing publications? Search for publications with a matching author name.